Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 6;26(1):45-53.
doi: 10.1002/jgf2.733. eCollection 2025 Jan.

Development of a Japanese version of the patient perceptions of deprescribing - Short form

Affiliations

Development of a Japanese version of the patient perceptions of deprescribing - Short form

Mio Kushibuchi et al. J Gen Fam Med. .

Abstract

Background: Deprescribing is a critical component of clinical practice, especially in geriatric medicine. Nevertheless, the attributes of patients who are prepared for, interested in, and could potentially benefit from deprescribing have not been well examined. The Patient Perceptions of Deprescribing (PPoD) evaluates patients' overall readiness for deprescribing and is complemented by an 11-item validated short form (SF-PPoD). The objective of this study was to develop a Japanese version of the SF-PPoD and assess its reliability and validity within Japanese older adults with polypharmacy.

Methods: The SF-PPoD was translated, back-translated, and assessed in a cognitive interview. We conducted a cross-sectional survey with 196 patients aged 65 years or older with five or more medications using the Japanese version to test for reliability and validity. We examined internal consistency and construct validity to determine if the Japanese sample responses reproduce the two subscales in the original SF-PPoD. Finally, we examined intra-person replicability using the intraclass correlation coefficient, in which 100 participants were invited and 93 participated.

Results: 118 males and 78 females, with a mean age of 79.2 [SD 6.5] years, completed the survey. Confirmatory factor analysis of the Japanese version of SF-PPoD revealed satisfactory structural validity with two-dimensional structure, "Motivation for Deprescribing" and "Primary Care Physician Relationship." Cronbach's alpha showed good internal consistency, and test-retest demonstrated acceptable intra-rater reliability.

Conclusions: We developed and validated a Japanese version of SF-PPoD with an 11-item, two-dimensional structure consistent with the original SF-PPoD. This scale may facilitate shared decision-making for medication optimization among older adults living with multimorbidity.

Keywords: deprescribing; geriatrics; patient perspectives; polypharmacy; primary health care; questionnaire.

PubMed Disclaimer

Conflict of interest statement

KI has received grant funding from the Japan Agency for Medical Research and Development (AMED) outside the submitted work (grunt number 22FK0108512H001). AML has received grant funding from VA Health Systems Research and her time is supported by resources from the VA Boston Healthcare System. She has received compensation from the US Deprescribing Research Network and AHRQ for deprescribing related work. MK, MT, and SMA: none to declare. KI is an Editorial Board member of the Journal of General and Family Medicine and a co‐author of this article. To minimize bias, he was excluded from all editorial decision‐making related to the acceptance of this article for publication.

Figures

FIGURE 1
FIGURE 1
Flowchart of the cross‐sectional study. a200 were initially included, but 4 completely withdrew participation at a later stage of the study, and thus 196 were included in the full dataset.
FIGURE 2
FIGURE 2
Path diagrams of the confirmatory factor analysis used to assess the structural validity. Squares represent the observed variable (questions 1–11), and ellipses represent the subscales. Single‐headed arrows from the ellipses to the squares represent factor loadings, the single‐headed arrow below each square represents residuals, and the double‐headed arrow represents factor correlations.

Similar articles

References

    1. Scott IA, Hilmer SN, Reeve E, Potter K, Le Couteur D, Rigby D, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827–834. - PubMed
    1. Davies LE, Spiers G, Kingston A, Todd A, Adamson J, Hanratty B. Adverse outcomes of polypharmacy in older people: systematic review of reviews. J Am Med Dir Assoc. 2020;21(2):181–187. - PubMed
    1. Rawle MJ, Cooper R, Kuh D, Richards M. Associations between polypharmacy and cognitive and physical capability: a British birth cohort study. J Am Geriatr Soc. 2018;66(5):916–923. - PMC - PubMed
    1. Muria Subirats E, Ballesta Ors J, Clua Espuny JL, González Henares MA, Tomas Q, Panisello Tafalla A, et al. Longterm mortality among chronic complex patients with polypharmacy: results of community‐ based prospective study. Gerontol Geriatr Stud [Internet]. 2018;2(1):e000529. 10.31031/GGS.2018.02.000529 - DOI
    1. Leelakanok N, D'Cunha RR. Association between polypharmacy and dementia – a systematic review and metaanalysis. Aging Ment Health. 2019;23(8):932–941. - PubMed

LinkOut - more resources